COVID-19 and Cancer in Victoria: impacts and opportunities of the clinical trial sector

Australia, and particularly Victoria, has an excellent reputation for delivering world-class clinical trials. Throughout the pandemic, clinical trial units have had to be agile, changing practices to ensure patient safety; closing some trials, conducting others via telehealth or moving patients to standard care.

The Victorian clinical trials sector is now preparing to re-open and increase recruitment. Potential opportunities include engaging with new research areas, providing special services and attracting increased trial activity.

Professor Eva Segelov, Director of Oncology at Monash Health, Dr Rob Blum, Clinical Director, Bendigo Health Oncology Unit and Ryan Hehir, Clinical Trials Manager at The Royal Children’s Hospital, will discuss how the Victorian clinical trials sector has been affected by the COVID-19 pandemic.

Narelle McPhee, Manager of Cancer Research at Bendigo Cancer Centre and Professor Nikolajs Zeps, Group Durector of Research and Development at Epworth HealthCare, will discuss how the Victorian health system can take advantage of opportunities presented by the pandemic shut down and build some strategies into the standard of care.

Professor Mark Rosenthal, VCCC Clinical Trials Development Lead and Director, Parkville Cancer Clinical Trials Unit will moderate the discussion.

Event details

1-2pm, Friday 12 June

Register for webinar here >>